Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biosensor for dengue virus detection: sensitive, rapid, and serotype specific.

Antje J Baeumner1, Nicole A Schlesinger, Naomi S Slutzki

  • 1Department of Biological and Environmental Engineering, Cornell University, Ithaca, New York, USA. ajb23@cornell.edu

Analytical Chemistry
|April 2, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advances in analytical methods for regulatory complement proteins in research and clinical applications.

Talanta·2026
Same author

Highlights of the 2026 Korean Society of Hypertension guidelines for the management of hypertension: what's new and what has changed.

Clinical hypertension·2026
Same author

Efficacy and Safety of Fimasartan/Indapamide Combination Therapy versus Fimasartan Monotherapy in Patients with Essential Hypertension Inadequately Responding to Fimasartan 30 mg (FINEDUO): A Randomized, Double-Blind, Multicenter, Phase III Study.

Drug design, development and therapy·2026
Same author

Low-Dose Telmisartan/Amlodipine in Essential Hypertension: A Phase III Trial.

Journal of clinical hypertension (Greenwich, Conn.)·2026
Same author

Irregularly Shaped Microplastic Particles Compromise the Integrity of the Glomerular Filtration Barrier of the Kidney.

Kidney360·2026
Same author

Impact of a mobile health education program on blood pressure and lipid profiles: a cohort study.

BMC public health·2026

A novel RNA biosensor rapidly detects Dengue virus serotypes 1-4 in blood within 15 minutes. This portable, inexpensive system, utilizing isothermal nucleic acid sequence-based amplification (NASBA), is ideal for point-of-care and field diagnostics.

Area of Science:

  • Biotechnology
  • Molecular Diagnostics
  • Virology

Background:

  • Dengue virus poses a significant global health threat, necessitating rapid and accurate diagnostic tools.
  • Existing Dengue virus detection methods can be time-consuming and require specialized laboratory equipment.
  • Point-of-care and field-deployable diagnostics are crucial for timely intervention and disease management.

Purpose of the Study:

  • To develop a serotype-specific RNA biosensor for the rapid detection of Dengue virus (DENV) serotypes 1-4.
  • To evaluate the biosensor's performance in terms of speed, portability, cost-effectiveness, and ease of use.
  • To assess the biosensor's accuracy and specificity compared to established laboratory-based detection systems.

Main Methods:

  • RNA amplification using isothermal nucleic acid sequence-based amplification (NASBA) coupled with a generic sequence attachment.

Related Experiment Videos

  • Development of a membrane-based DNA/RNA hybridization system utilizing liposome amplification.
  • Utilization of generic and serotype-specific DNA probes for Dengue virus RNA detection via a portable reflectometer.

    • Main Results:

    • The developed biosensor enables rapid detection of Dengue virus RNA in just 15 minutes.
    • The system demonstrated excellent correlation with laboratory-based detection methods.
    • Clinical sample testing showed correct identification of Dengue serotypes 1, 2, and 4, with minor cross-reactivity noted for serotype 3.

    Conclusions:

    • The RNA biosensor is a promising tool for rapid, specific, and sensitive Dengue virus detection.
    • Its portable and user-friendly design makes it suitable for point-of-care and field applications.
    • Further optimization may be needed to completely eliminate cross-reactivity for all serotypes, particularly Dengue serotype 3.